Basilea submits European Marketing Authorization Application of ceftobiprole for the treatment of pneumonia – NBCNews.com

Basilea Pharmaceutica Ltd. (SIX: BSLN) today announced that it has submitted a Marketing Authorization Application (MAA) under the European decentralized procedure for its novel investigational antibiotic ceftobiprole, a broad-spectrum anti-MRSA …